Sponsor pipeline

Dallas VA Medical Center clinical trial pipeline

Get alerts when Dallas VA Medical Center's trials change

2 active trials 1 recruiting 2 disease areas 4 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-09-16

What changed in the last 30 days

2026-09-03
notable
Enrollment closed, study ongoing
Primary completion 2026-07-01, at least 182 days after the final estimate of 2025-12
Final enrollment: 21 participants (planned 60)
Completion pushed: 2025-12 → 2026-12
NCT04244630 Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial · Phase 2

Active trials by phase

Phase 2
2

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT04018872 Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal… Esophagus Adenocarcinoma Recruiting 2021-11-04
NCT04244630 Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial Amyotrophic Lateral Sclerosis (ALS) Active, Not Recruiting 2026-09-02

Disease areas by active trials

Get alerts when Dallas VA Medical Center's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free